Analysis of myoCAF-rich TC-1 and MC38 tumors by IHC showed that ATM inhibition (fibroblast shRNA knockdown and AZD0156) resulted in a significant relocation of CD8 T cells from the tumor periphery to the tumor core (Fig. 6A–D, G, and H; Supplementary Fig. S6A and S6B). The gene discussed is CD8A; the disease is neoplasm.